Parallel design clinical trial

Parallel design clinical trial

The number of patients or experimental units required for the trial. The probability that a clinical trial will have a significant(positive) result, that is have a p-value of less than the specified significance level(usually 5%). This probability is…

Registry clinical trials design

Registry clinical trials design

(PDF) document. Describes review criteria for study records submitted to the registry (Draft, August 2010) (PDF) document. Describes review criteria for each scientific module in the results section of the study record submitted to the results database…

Clinical trial designs

Clinical trial designs

In order to reduce the diversity gap between men and women and among various subpopulations represented in clinical trials, and to moderate the costs of these studies, we need to innovate in trial design. In other words, we need to think outside the box…

Clinical trial design in kidney transplantation

Clinical trial design in kidney transplantation

Since the introduction of cyclosporine [1, 2], there has been a dramatic increase in the number of successful renal transplants and use of non-cyclosporine immunosuppressive agents [3-20]. As the donor and recipient selection criteria for transplantation…

Phase II clinical trials designed cancer

Phase II clinical trials designed cancer

The term “phase” is used to describe the goals of a clinical trial. Phase I clinical trials are used to show that a new treatment is safe for a small group of people and to find the best dose and schedule for future research of the drug or drug combination…

Adaptive clinical trial design Conference

Adaptive clinical trial design Conference

Aptiv Solutions will be sponsoring a one-day conference focused on ‘Delivering Innovation and Efficiency Through Adaptive Clinical Trials, ’ on October 22, 2012. In partnership with Berry Consultants and Tessella, Aptiv will provide a forum for pharmaceutical…